We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




AI-Based System to Guide Stroke Treatment Decisions Reduces Chances of New Vascular Events

By HospiMedica International staff writers
Posted on 12 Feb 2024
Print article
Image: Ischemic stroke animation (Photo courtesy of American Stroke Association)
Image: Ischemic stroke animation (Photo courtesy of American Stroke Association)

Ischemic strokes, which occur when blood vessels to the brain are narrowed or clogged, cutting off blood flow, accounted for approximately half of the 7.44 million stroke-related deaths globally in 2021. Rapid and accurate evaluation and treatment decisions are crucial in such cases to restore blood flow and reduce brain damage. Now, an artificial intelligence (AI) system designed to assist in making treatment decisions for stroke patients has shown promise. It has improved the quality of stroke care and reduced the incidence of recurrent strokes, heart attacks, and vascular deaths among stroke survivors within three months after experiencing a stroke.

In a research study conducted across hospitals in China, researchers at Capital Medical University (Beijing, China) compared the effectiveness of AI-based evaluation and treatment for ischemic stroke patients with standard care provided by stroke teams. The findings, presented at the International Stroke Conference 2024 held by the American Stroke Association (Dallas, TX, USA), revealed that ischemic stroke survivors who received AI-based care recommendations experienced fewer recurrent strokes, heart attacks, or vascular deaths within three months compared to those who received traditional stroke treatment.

The clinical trial, named GOLDEN BRIDGE II, involved 77 hospitals in China. These hospitals were randomly assigned to provide diagnosis and treatment for ischemic stroke patients based either on AI system recommendations or on assessments and recommendations by the hospitals' stroke care teams. The AI system used in the trial combined participants' brain imaging scans, interpreted by AI, with established clinical knowledge for stroke diagnosis, classification, and guideline-recommended treatment and strategies for preventing secondary strokes. The study, which included over 20,000 participants, measured the number of vascular events – such as ischemic and hemorrhagic strokes, heart attacks, or vascular-related deaths – during a three-month follow-up period after the initial ischemic stroke.

The use of the AI-based clinical decision support system was found to reduce the risk of new vascular events by 25.6% in the three months following the initial stroke. This approach also enhanced the quality of stroke care, with patients more likely to receive treatment in line with medical guidelines. After three months, participants treated in AI-supported hospitals experienced fewer total vascular events compared to those receiving standard post-stroke evaluation and treatment (2.9% vs. 3.9%). No significant differences in physical disability levels were observed between the two groups when assessed using the modified Rankin Scale Score, a tool for determining disability levels in stroke patients.

“This research showed that an artificial intelligence-based clinical decision support system for stroke care was effective and feasible in clinical settings in China and improved patient outcomes,” said lead study author Zixiao Li, M.D., Ph.D. “The reduction in new vascular events is a significant finding because it shows that AI has the potential to make a real difference in stroke care and benefit this large population of stroke survivors.”

Related Links:
Capital Medical University
American Stroke Association

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.